ARKG

Fund Description
The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.
Fund Profile
Fund Name ARK Genomic Revolution Multi-Sector ETF
Fund Exchange Ticker ARKG
Fund Sponsor ARK Funds
Fund ISIN US00214Q3020
Net Expense Ratio 0.75 %
Fund Inception Date 31 October 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Active
Index Name Not Applicable
Index Provider Not Applicable
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Funds Combining Developed & Emerging Exposure
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 6 August 2020
Asset Under Management 1761.50 Million (USD)
1 Month Total Return 0.19 %
Year To Date Return 72.26 %
1 Year Total Return 84.21 %
3 Year Annualized Total Return 39.26 %
NAV 57.65
Share Outstanding 30,555,000
Top 10 Holdings (7 August 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
CRISPR THERAPEUTICS AG CRSP EQUI 0.1039000000
INVITAE CORP NVTA EQUI 0.0997000000
ARCTURUS THERAPEUTICS HOLDIN ARCT EQUI 0.0648000000
ILLUMINA INC ILMN EQUI 0.0573000000
COMPUGEN LTD CGEN EQUI 0.0532000000
TWIST BIOSCIENCE CORP TWST EQUI 0.0419000000
EDITAS MEDICINE INC EDIT EQUI 0.0375000000
IOVANCE BIOTHERAPEUTICS INC IOVA EQUI 0.0349000000
CAREDX INC CDNA EQUI 0.0309000000
PERSONALIS INC PSNL EQUI 0.0308000000